BlackRock’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $655K | Sell |
467,673
-1,479,273
| -76% | -$2.07M | ﹤0.01% | 4312 |
|
|
2025
Q1 | $3.13M | Sell |
1,946,946
-25,095
| -1% | -$40.4K | ﹤0.01% | 3796 |
|
|
2024
Q4 | $2.48M | Buy |
1,972,041
+33,483
| +2% | +$42.2K | ﹤0.01% | 3924 |
|
|
2024
Q3 | $3.64M | Buy |
1,938,558
+63,133
| +3% | +$119K | ﹤0.01% | 3773 |
|
|
2024
Q2 | $13.9M | Buy |
1,875,425
+166,437
| +10% | +$1.23M | ﹤0.01% | 3145 |
|
|
2024
Q1 | $13.4M | Buy |
1,708,988
+17,074
| +1% | +$134K | ﹤0.01% | 3144 |
|
|
2023
Q4 | $8.59M | Sell |
1,691,914
-72,982
| -4% | -$371K | ﹤0.01% | 3402 |
|
|
2023
Q3 | $10.4M | Buy |
1,764,896
+66,226
| +4% | +$392K | ﹤0.01% | 3253 |
|
|
2023
Q2 | $12.6M | Buy |
1,698,670
+1,151,187
| +210% | +$8.54M | ﹤0.01% | 3234 |
|
|
2023
Q1 | $5.17M | Buy |
547,483
+65,081
| +13% | +$615K | ﹤0.01% | 3546 |
|
|
2022
Q4 | $5.14M | Buy |
482,402
+229,548
| +91% | +$2.44M | ﹤0.01% | 3641 |
|
|
2022
Q3 | $1.87M | Buy |
252,854
+21,038
| +9% | +$155K | ﹤0.01% | 4141 |
|
|
2022
Q2 | $1.11M | Buy |
231,816
+866
| +0.4% | +$4.16K | ﹤0.01% | 4406 |
|
|
2022
Q1 | $1.18M | Buy |
230,950
+2,618
| +1% | +$13.4K | ﹤0.01% | 4520 |
|
|
2021
Q4 | $1.37M | Buy |
228,332
+9,089
| +4% | +$54.6K | ﹤0.01% | 4485 |
|
|
2021
Q3 | $1.94M | Sell |
219,243
-3,289
| -1% | -$29.1K | ﹤0.01% | 4272 |
|
|
2021
Q2 | $1.76M | Buy |
222,532
+22,699
| +11% | +$180K | ﹤0.01% | 4265 |
|
|
2021
Q1 | $1.52M | Buy |
199,833
+179
| +0.1% | +$1.36K | ﹤0.01% | 4316 |
|
|
2020
Q4 | $1.56M | Buy |
199,654
+1,334
| +0.7% | +$10.4K | ﹤0.01% | 4032 |
|
|
2020
Q3 | $1.92M | Sell |
198,320
-102,388
| -34% | -$992K | ﹤0.01% | 3818 |
|
|
2020
Q2 | $3.17M | Buy |
300,708
+233,790
| +349% | +$2.47M | ﹤0.01% | 3616 |
|
|
2020
Q1 | $390K | Buy |
66,918
+27,601
| +70% | +$161K | ﹤0.01% | 4029 |
|
|
2019
Q4 | $257K | Buy |
39,317
+23,374
| +147% | +$153K | ﹤0.01% | 4227 |
|
|
2019
Q3 | $110K | Buy |
15,943
+55
| +0.3% | +$379 | ﹤0.01% | 4375 |
|
|
2019
Q2 | $117K | Buy |
15,888
+76
| +0.5% | +$560 | ﹤0.01% | 4383 |
|
|
2019
Q1 | $228K | Buy |
15,812
+62
| +0.4% | +$894 | ﹤0.01% | 4173 |
|
|
2018
Q4 | $183K | Buy |
15,750
+76
| +0.5% | +$883 | ﹤0.01% | 4204 |
|
|
2018
Q3 | $348K | Buy |
15,674
+21
| +0.1% | +$466 | ﹤0.01% | 4139 |
|
|
2018
Q2 | $301K | Sell |
15,653
-5,966
| -28% | -$115K | ﹤0.01% | 4170 |
|
|
2018
Q1 | $237K | Sell |
21,619
-292
| -1% | -$3.2K | ﹤0.01% | 4126 |
|
|
2017
Q4 | $437K | Buy |
21,911
+1,131
| +5% | +$22.6K | ﹤0.01% | 4019 |
|
|
2017
Q3 | $358K | Buy |
20,780
+642
| +3% | +$11.1K | ﹤0.01% | 4050 |
|
|
2017
Q2 | $737K | Sell |
20,138
-3,255
| -14% | -$119K | ﹤0.01% | 3874 |
|
|
2017
Q1 | $1.06M | Buy |
+23,393
| New | +$1.06M | ﹤0.01% | 3759 |
|